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SHORT ABSTRACT: 
The current priority in breast cancer radiotherapy is to reduce cardiac doses without 
compromising target tissue coverage. The voluntary breath-hold technique described here is a 
simple, inexpensive solution to this problem and capable of being instituted widely without the 
need for specialized equipment. 
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LONG ABSTRACT: 
Breath-holding techniques reduce the amount of radiation received by cardiac structures 
during tangential-field left breast radiotherapy. With these techniques, patients hold their 
breath while radiotherapy is delivered, pushing the heart down and away from the 
radiotherapy field. Despite clear dosimetric benefits, these techniques are not yet in 
widespread used. One reason for this is that commercially available solutions require specialist 
equipment, necessitating not only significant capital investment, but often also incurring 
ongoing costs such as a need for daily disposable mouthpieces. The voluntary breath-hold 
technique described here does not require any additional specialist equipment. All breath-
holding techniques require a surrogate to monitor breath-hold consistency and whether 
breath-hold is maintained. Voluntary breath-hold uses the distance moved by treatment room 
lasers from the anterior and lateral reference marks (tattoos) in breath-hold to monitor 
consistency at CT-planning and treatment setup. Light fields are then used to monitor breath-
hold consistency prior to and during radiotherapy delivery. 
 
INTRODUCTION: 
Cancer is a leading cause of death worldwide, accounting for 7.6 million deaths in 20081. Of all 
cancers, breast cancer is the most common with an incidence of over 13.8 million worldwide, 
and this incidence is increasing1. However, improvements in the diagnosis and treatment of 
breast cancer mean that the number of women surviving their breast cancer is also increasing, 
and is estimated to treble to 1.7 million by 2040 in the UK alone2. Breast radiotherapy forms an 
important part of many women’s breast cancer treatment, halving their risk of breast cancer 
recurrence and reducing the risk of breast cancer death by 3.8%3. With improvements in breast 
cancer survivorship, any long-term side-effects caused by breast cancer treatments are 
increasingly important. An innocent bystander in breast radiotherapy is the heart, which is 
exposed to unwanted radiation as a result of its proximity to radiation fields, especially during 
left breast irradiation. It is this unwanted dose to the heart that accounts for the 1% increase in 
non-breast cancer deaths associated with breast radiotherapy4. Recent evidence suggests that 
there is no threshold dose below which the late cardiac effects of breast radiotherapy do not 
occur5, making it critical for the oncology community to establish techniques which minimize 
cardiac doses without compromising breast tissue coverage. However, since breast 
radiotherapy accounts for approximately 30% of all radiotherapy treatments6, any new 
technique must be simple and inexpensive in order to be sustainable and avoid an 
unacceptable burden on healthcare resources. 
 
There are a number of techniques which may be employed to reduce heart doses during breast 
radiotherapy. Multileaf collimation (MLC) is widely used in the UK [Royal College of 
Radiologists’ (UK) audit 2012] and although effective at sparing heart tissue, it risks 
simultaneously shielding breast tissue. Inverse-planned intensity modulated radiotherapy 
(IMRT) improves target tissue conformality7, but may also increase low-dose irradiation of the 
heart, lungs and contralateral breast7,8. An increase in low dose irradiation of the heart is 
undesirable, particularly in light of the data from Darby et al.5. In addition, inverse-planned 
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IMRT is more resource-intensive, requiring greater physics and quality assurance (QA) time and 
expertise. Treating women in the prone (face-down) position may reduce cardiac doses in 
larger-breasted women9, however, questions remain over the positional reproducibility of this 
technique10. Breath-holding techniques, in which patients hold their breath during radiotherapy 
delivery, result in the heart being pushed down and away from the radiotherapy fields and may 
minimize the need for a compromise between target tissue coverage and organ-at-risk (OAR) 
sparing (Figure 1)11. 
 
There are currently two main breath-holding techniques in clinical use. The first consists of a 
digital spirometer attached to a balloon valve. Patients breathe through a mouthpiece and a 
clip is placed on their nose to avoid nasal respiration. The spirometry trace is visualized on a 
monitor, and inspiration interrupted and held at a predetermined lung volume. The second 
method was primarily designed for use as a respiratory gating system, although it also has an 
in-built breath-hold setting. This system uses a video camera to record the motion of an 
infrared-reflecting marker placed on the chest of the patient. The vertical movement of the 
marker is displayed in real-time on a monitor, and treatment delivery commences once the 
marker moves into a pre-specified threshold zone. Both systems markedly reduce cardiac doses 
in patients receiving left breast radiotherapy. The spirometry-based technique significantly 
reduces the volume of myocardium irradiated12-14, as well as demonstrating comparable intra- 
and inter-fraction reproducibility compared to standard supine free-breathing breast 
radiotherapy15. Similarly, treatment using the infrared-reflecting markers reduces the mean 
dose to the heart by over 50%11,16,17, whilst maintaining target tissue coverage11. Such 
dosimetric savings are projected to equate to a 10-fold reduction in cardiac deaths18. 
 
A drawback of these systems, however, and a barrier to widespread implementation, is their 
cost. Both systems require investment in the devices themselves, however, in the case of the 
spirometry system there are also ongoing costs as the mouthpieces are disposable, requiring a 
new mouthpiece for planning-CT as well as for each fraction of treatment. Cost, coupled with a 
lack of staff training, explains why only 4% of UK breast treatments were performed using 
breath-holding techniques in 2012 [Royal College of Radiologists’ (UK) audit]. Breath-holding 
techniques are in more widespread use in the rest of Europe, with 20% of centers using these 
techniques in 201019. One explanation for this is the development and implementation of a 
simple, inexpensive and equipment-free breath-holding technique, voluntary breath-hold 
(VBH). Until recently, however, data was lacking on the reproducibility of the VBH technique. A 
randomized study conducted at the Royal Marsden Hospital (Sutton, UK), The UK HeartSpare 
Study, has demonstrated that interfraction reproducibility with the VBH technique is 
comparable to that with the spirometry-based device. In addition, the VBH technique offers a 
time advantage at planning-CT and treatment setup and is preferred by patients and 
radiographers alike20. The VBH technique is currently being rolled out to five UK radiotherapy 
centers to confirm that the technique is feasible in a multicenter setting and that heart-sparing 
is maintained (HeartSpare II). It is expected that this will pave the way for the UK-wide uptake 
of heart-sparing breast radiotherapy, and is likely to lead to a significant reduction in heart 
disease among UK breast cancer survivors. 
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PROTOCOL:  
 
The study through which this protocol was implemented was approved by the Royal Marsden 
Committee for Clinical Research (Sutton, UK) and the Research Ethics Committee (London – 
Riverside, UK) (ISRCTN 53485935). 
 
1. Radiotherapy clinic 
 
1.1) Assess patient suitability for the voluntary breath-hold technique in the clinic: left breast 
or chest wall radiotherapy (without nodal irradiation) recommended by radiation oncologist.  
 
1.2) Review the patient’s performance status and comorbidities (especially lung-related). 
  
1.3) Ask the patient to practice holding their breath at home, while lying down, initially for 5 
seconds, and building up in 5 second intervals to 20 seconds.  
 
2. Radiotherapy planning-CT session 
 
2.1) Position the patient on the CT couch in the standard treatment position.  
 
2.2) Define the position of tattoos and place CT markers (crosses) on the patient midline in 
free-breathing, approximately half way along the likely field edges. Add lateral markers to each 
side of the patient in free-breathing, in line with the midline marker.  
 
2.3) Ask the patient to practice taking a deep breath in and holding it, initially for 5 seconds, 
before building up in 5 second intervals to 20 seconds.  Instruct the patient to breathe in and 
breathe out twice before asking them to hold their breath for up to 20 seconds. This relaxes the 
patient, helps them prepare for the breath-hold and helps breath-hold consistency. 
 
2.4) Record the maximum duration for which the patient can comfortably hold their breath. 
 
2.5) Repeat the breath-hold and mark the position of the anterior and lateral tattoos in 
relation to the lasers in breath-hold to help establish reproducibility.  Record the height of the 
lateral tattoo above the couch top during breath-hold before proceeding with the CT scan.   
 
2.6) Give the standard breath-hold instructions to the patient and start the scan once 
satisfied the patient is in breath-hold. 
 
2.7) Once the CT scan has been completed, check and record the height of the lateral tattoos 
on the CT scan to confirm that a consistent breath-hold was performed.  If the lateral couch 
height differs by greater than 3mm from the initial couch height, re-measure the anterior and 
lateral reference points. 
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3. Radiotherapy treatment planning 
 
Note: the radiotherapy treatment planning process is the same as for a standard breast patient. 
 
3.1) Apply tangential radiotherapy fields according to local protocol. 
 
3.2) Produce clinical radiotherapy treatment plan which fulfills ICRU criteria. 
 
3.3) Record the anterior beam source-to-skin distance (SSD) in addition to recording 
standard treatment planning data (according to local protocol). 
 
Note: the anterior beam SSD is used to check the anterior-posterior setup in the treatment 
room. 
 
4. Radiotherapy treatment setup 
 
4.1) Align the tattoos in free-breathing.  Mark the posterior and inferior measurements from 
the left lateral tattoo and the anterior midline tattoo on the patient’s skin (from information 
recorded at planning-CT session).   
 
4.2) Instruct the patient to breathe in and out twice before taking a deep breath in and 
holding. The reference mark on the patient’s skin should rise up to the level of the laser.  Ask 
the patient to repeat the breath-hold procedure a couple of times to confirm reproducibility 
before proceeding with patient setup. 
 
4.3) Ask the patient to perform a breath-hold and align the midline tattoo to the isocenter 
position superior/inferior and set the field-to-skin distance (FSD) at the midline. 
 
4.4) In free-breathing, move the bed laterally to the isocenter.  
 
4.5) Measure and mark the medial and lateral field borders in free-breathing. 
 
4.6) Set all other machine parameters (eg. field size and gantry, collimator and couch angles) 
for the first beam (anterior oblique). Ask the patient to perform a breath-hold and check the 
medial border aligns with mark made in 4.5.  
 
4.7) Mark the field edge (as defined by the light field) with a pen at every fraction: this aids 
visualization of the patient’s breath-hold. 
 
4.8) Repeat steps 4.6 and 4.7 for the posterior oblique beam, and treat using this beam first. 
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4.9) If patient setup is out of tolerance (according to local tolerance levels for a standard 
breast radiotherapy patient), refer to the troubleshooting algorithm (Figure 2). 
 
4.10) If there are insufficient cameras to monitor the field edge as well as the position of the 
gantry relative to the couch from the control room, assess gantry rotation prior to leaving the 
treatment room in order to avoid collisions. 
 
5. Radiotherapy treatment delivery 
 
5.1) Once in the control room, zoom the treatment room cameras so that the field borders 
marked on the patient’s skin are visible on the control room monitors. 
 
5.2) Once ready to commence treatment, ask the patient to perform a breath-hold (as 
detailed in 4.2) via the intercom system. Check the light field aligns satisfactorily with the 
marked field border and then commence treatment (Figure 3).  
 
5.3) Monitor the patient’s breath-hold during treatment delivery. Treatment should be 
interrupted if there is concern that there has been a change in breath-hold depth. 
 
6. Radiotherapy treatment verification 
 
6.1) Perform imaging verification of patient position (such as with electronic portal imaging 
(EPI) or cone-beam CT), following local protocols for type/frequency of imaging and tolerance 
levels. 
 
6.2) Correct for systematic errors with isocenter moves according to local protocols for 
standard breast radiotherapy patients. Adjustment of marks on the patient’s skin should not be 
necessary. 
 
REPRESENTATIVE RESULTS:  
Real-time electronic portal images (EPI) were matched on-line to digitally reconstructed 
radiographs (DRRs) for 23 patients (172 treatment fractions). EPI displacements were analyzed 
for the right anterior and left posterior oblique beams in the (u,v)-plane (v-direction parallel to 
craniocaudal axis and u-direction perpendicular to this)21, and setup errors for the VBH 
technique estimated. EPI-based population systematic error range (for each beam and in each 
plane) was 1.5-1.8mm and random error range 1.7-2.5mm.  
 
Tabular dose-volume histogram (DVH) data was used to derive the NTDmean (a biologically 
weighted mean of total dose to tissue normalized to 2Gy fractions using a standard linear 
quadratic model22, α/β=3Gy) for heart, left anterior descending coronary artery (LAD), 
ipsilateral and whole lungs. In addition, the maximum dose received by the LAD (LADmax) was 
estimated. Normal tissue doses are shown in Table 1.  
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Times for planning-CT session, treatment setup, treatment delivery and total treatment session 
were recorded, and are shown in Table 2. The data demonstrate that planning-CTs can be 
completed within a standard 30 minute session. Treatment times include CBCT imaging, which 
was performed for every third fraction. Treatment setup and total session times are, therefore, 
expected to be shorter than reported here for centers in which CBCT imaging is not part of 
standard treatment. However, even with CBCT imaging, treatments may be completed within a 
20 minute treatment session. 
 
Patients and radiographers were asked to complete validated questionnaires23 at their 
planning-CT session as well as twice during their treatment. Sixty-five patient questionnaires 
and 64 radiographer questionnaires were analyzed. The questionnaires were summarized as 
patient comfort scores (PCS) and radiographer satisfaction scores (RSS) (out of 9, higher score = 
more comfortable/satisfactory). Median PCS was 8 (interquartile range 8-9) and median RSS 
was 7 (interquartile range 6-8). 
 
Figure 1: The heart-sparing effect of VBH. Axial and sagittal CT slices from the same patient at 
the same chest wall level in free-breathing (Figures 1A and 1C) and using the VBH technique 
(Figures 1B and 1D). Note that the heart (outlined in yellow) has been pushed down and away 
from the radiotherapy fields using the VBH technique.  
 
Figure 2: Troubleshooting algorithm for voluntary breath-hold technique treatment setup. 
This algorithm may be used to assist treatment setup where patients are not setting up within 
tolerance (according to local tolerance levels). As an example, our center uses a 5mm tolerance 
level. The algorithm should be followed from top to bottom. In the majority of cases, setup can 
be brought within tolerance by asking the patient to modify their breath-hold depth (deeper or 
shallower as required). 
 
Figure 3: Checking breath-hold consistency from the control room. Control room CCTV stills 
demonstrating the position of the light field relative to the marked field border for a right 
anterior oblique beam in free-breathing (Figure 3A) and the aligning of the light field and 
marked field border once the patient is in breath-hold (Figure 3B). 
 
Table 1: Normal tissue doses for the voluntary breath-hold (VBH) technique. Median, 
minimum and maximum NTDmean (Gy) for heart, LAD, ipsilateral and whole lungs are shown, as 
are median, minimum and maximum LADmax (Gy). In addition, median, minimum and maximum 
cardiac doses for standard free-breathing (FB) left breast radiotherapy at our center are shown 
for comparison. 
 
Table 2: Planning-CT and treatment session times for the voluntary breath-hold technique. 
Median, minimum and maximum planning-CT, treatment setup, treatment delivery and total 
treatment session times are shown (mins). 
 
DISCUSSION: 
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Critical steps in the protocol include: 1) checking for breath-hold consistency at planning-CT and 
treatment setup; 2) checking the lateral couch height measured on CT is consistent with that 
measured pre-CT; 3) aligning tattoos in free-breathing but setting FSD in breath-hold; 4) 
ensuring light field aligns with marked field borders prior to commencing treatment. 
 
The number of breath-holds required during treatment delivery varies from patient to patient, 
and is primarily dependent on the number of segments being delivered. Suitable interruption 
points during treatment delivery (to enable the patient to relax before repeating a breath-hold) 
should be determined on an individual basis depending on the method of delivery. We would 
strongly suggest that for initial implementation of VBH that a consistent team is used. This 
enables those involved to become competent more quickly and helps maintain treatment 
quality. Where problems are encountered during treatment setup, the patient may be asked to 
modify their breath-hold (deeper or shallower as required). If this fails to improve setup, the 
patient should be set up again. Vector couch moves should be employed as a last resort. A 
troubleshooting algorithm is shown in Figure 2. 
 
[Place Figure 2 here] 
 
Population systematic and random treatment setup errors are less than those seen in free-
breathing tangential field breast radiotherapy24, and consistent with other published data on 
breath-holding techniques25,26. VBH reduces median normal tissue doses by 25-58% compared 
with standard free-breathing breast radiotherapy at our center (Table 1). Cardiac doses with 
VBH are lower than those seen in other published work on breath-holding 
techniques11,16,17,26,27, although methods of recording dose data vary between these studies. 
 
As described in the introduction, all breath-hold techniques use a surrogate to measure inter- 
and intrafraction reproducibility. The VBH technique uses alignment of the light field with 
marked field borders to check for consistency before commencing treatment and during 
treatment delivery. Although not yet formally reported, we have found intrafraction 
reproducibility (measured using multiple intrafraction EPIs) to be extremely good, with little, if 
any, intrafraction movement. This is consistent with previously published work26. Given the 
consistent intrafraction reproducibility observed, radiotherapy systems in which light fields do 
not remain on during treatment delivery need not be a barrier to implementation of VBH. In-
room lasers may be used as an alternative to light fields for checking that the breath-hold is 
maintained during treatment delivery. 
 
VBH offers significant advantages over other heart-sparing techniques, some of which have 
already been alluded to. It minimizes the trade-off between target and OAR compromise often 
required when using MLC, it reduces the low-dose irradiation of the heart and is much less 
resource-intensive than IMRT, and it is more reproducible than prone irradiation whilst 
benefiting women of all breast sizes. With respect to other breath-holding techniques, VBH 
gives comparable reproducibility and heart-sparing, while being less expensive to implement as 
no specialist equipment is required. The low cost of the technique means that there is a very 
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real opportunity for it to benefit other healthcare systems, especially those with limited 
resources. 
 
There is already published work demonstrating the feasibility of delivering nodal irradiation in 
addition to whole breast/chest wall irradiation using the infrared-reflecting markers17 and 
spirometry-based14 systems. Our center is now performing further work to confirm the 
feasibility of using VBH for nodal irradiation in breast cancer patients. Inverse-planned IMRT is 
likely to be of benefit in selected patients, especially when delivering a simultaneous integrated 
boost, and the feasibility of using VBH in these patients needs to be assessed. Finally, breath-
holding techniques may be of benefit when treating other tumors, including lung28, liver29 and 
gastric30 cancers. Further work is needed to assess the suitability of using the VBH technique for 
treating sites other than breast. 
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